T.B.H. (Theo) Geijtenbeek
VU University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by T.B.H. (Theo) Geijtenbeek.
Journal of Immunology | 2002
Hermelijn H. Smits; Esther C. de Jong; Joost H. N. Schuitemaker; T.B.H. (Theo) Geijtenbeek; Yvette van Kooyk; Martien L. Kapsenberg; Eddy A. Wierenga
Th cell polarization toward Th1 or Th2 cells is strongly driven by exogenous cytokines, in particular IL-12 or IL-4, if present during activation by Ag-presenting dendritic cells (DC). However, additional Th cell polarizing mechanisms are induced by the ligation of cell surface molecules on DC and naive Th cells. In the present study, the role of LFA-1/ICAM-1 ligation in human Th cell polarization was investigated. Triggering of LFA-1 on anti-CD3/CD28 stimulated naive Th cells with immobilized Fc-ICAM-1, in the absence of DC and exogenous cytokines, induced a marked shift toward Th1 cell development, accompanied by a dose-dependent decrease in GATA-3 expression and a dose-dependent increase in T-bet expression. Th1 polarization by LFA-1 ligation could be demonstrated only under low cytokine conditions, as it was largely overruled by IL-12 or IL-4. This IL-12-independent Th1-driving mechanism appears to be operated by certain subsets of effector DC. Maturation of DC by poly(I:C), a synthetic dsRNA, used as an in vitro model for viral infections, leads to the generation of Th1-driving effector DC (DC1), which express elevated levels of ICAM-1 but produce only low levels of IL-12p70. Blocking the ICAM-1/LFA-1 interaction in cocultures of these DC with naive Th cells attenuated their Th1-driving capacity. The molecular mechanism by which LFA-1 signaling supports Th1 differentiation is blocked by specific inhibitors of extracellular signal-regulated kinase phosphorylation. The present data indicate the existence of an IL-12-independent, extracellular signal-regulated kinase-mediated mechanism, through which high ICAM-1-expressing DC1 can drive Th1 polarization. This mechanism may be operational during viral infections.
Cellular Microbiology | 2008
Ben J. Appelmelk; J. den Dunnen; Nicole N. Driessen; Roy Ummels; M. Pak; Jérôme Nigou; Gérald Larrouy-Maumus; Sudagar S. Gurcha; Farahnaz Movahedzadeh; Jeroen Geurtsen; Eric J. Brown; M. M. Eysink Smeets; Gurdyal S. Besra; P. T. J. Willemsen; Todd L. Lowary; Y. van Kooyk; Janneke J. Maaskant; Neil G. Stoker; P. Van Der Ley; Germain Puzo; Christina M. J. E. Vandenbroucke-Grauls; Catharina W. Wieland; T. Van Der Poll; T.B.H. (Theo) Geijtenbeek; A. M. Van Der Sar; Wilbert Bitter
Pathogenic mycobacteria have the ability to persist in phagocytic cells and to suppress the immune system. The glycolipid lipoarabinomannan (LAM), in particular its mannose cap, has been shown to inhibit phagolysosome fusion and to induce immunosuppressive IL−10 production via interaction with the mannose receptor or DC‐SIGN. Hence, the current paradigm is that the mannose cap of LAM is a crucial factor in mycobacterial virulence. However, the above studies were performed with purified LAM, never with live bacteria. Here we evaluate the biological properties of capless mutants of Mycobacterium marinum and M. bovis BCG, made by inactivating homologues of Rv1635c. We show that its gene product is an undecaprenyl phosphomannose‐dependent mannosyltransferase. Compared with parent strain, capless M. marinum induced slightly less uptake by and slightly more phagolysosome fusion in infected macrophages but this did not lead to decreased survival of the bacteria in vitro, nor in vivo in zebra fish. Loss of caps in M. bovis BCG resulted in a sometimes decreased binding to human dendritic cells or DC‐SIGN‐transfected Raji cells, but no differences in IL‐10 induction were observed. In mice, capless M. bovis BCG did not survive less well in lung, spleen or liver and induced a similar cytokine profile. Our data contradict the current paradigm and demonstrate that mannose‐capped LAM does not dominate the Mycobacterium–host interaction.
Journal of Parenteral and Enteral Nutrition | 2000
Geert Wanten; T.B.H. (Theo) Geijtenbeek; R.A.P. Raymakers; Yvette van Kooyk; Dirk Roos; Jan B.M.J. Jansen; Anton H. Naber
BACKGROUND To test the hypothesis that lipid emulsions with different triglyceride structures have distinct immunomodulatory properties, we analyzed human neutrophil adhesion and degranulation after lipid incubation. METHODS Neutrophils, isolated from the blood of 10 healthy volunteers, were incubated in medium or physiologic (2.5 mmol/L) emulsions containing long-chain (LCT), medium-chain (MCT), mixed LCT/MCT, or structured (SL) triglycerides. Expression of adhesion molecules and degranulation markers was evaluated by flow cytometry. Also, functional adhesion was investigated by means of a flow cytometric assay using fluorescent beads coated with the integrin ligand intercellular adhesion molecule (ICAM)-1. RESULTS Although LCT and SL had no effect, LCT/MCT significantly increased expression of the beta2 integrins lymphocyte-function-associated antigen 1 (+18%), macrophage antigen 1 (+387%), p150,95 (+82%), and (alphaDbeta2 (+230%). Degranulation marker expression for azurophilic (CD63, +210%) and specific granules (CD66b, +370%) also significantly increased, whereas L-selectin (CD62L, -70%) decreased. The effects of LCT/MCT were mimicked by the MCT emulsion. ICAM-1 adhesion (% beads bound) was increased by LCT/MCT (34% +/- 4%), whereas LCT (19% +/-3%) and SL (20% +/- 2%) had no effect compared with medium (17% +/- 3%). CONCLUSIONS LCT/MCT and MCT, contrary to LCT and SL emulsions, increased neutrophil beta2 integrin expression, adhesion, and degranulation. Apart from other emulsion constituents, triglyceride chain length might therefore be a key feature in the interaction of lipid emulsions and the phagocyte immune system.
Blood | 1999
T.B.H. (Theo) Geijtenbeek; Y. van Kooyk; S.J. van Vliet; Maurits H. Renes; R.A.P. Raymakers; Carl G. Figdor
Blood | 1999
T.B.H. (Theo) Geijtenbeek; Ruurd Torensma; S.J. van Vliet; G.C.F. van Duijnhoven; Jeena Middel; I.L.M.H.A. Cornelissen; Gosse J. Adema; Hans S. L. M. Nottet; Carl G. Figdor; Y. van Kooyk
Archive | 2013
Martien L. Kapsenberg; Eddy A. Wierenga; T.B.H. (Theo) Geijtenbeek; Yvette van Kooyk
Comparative Biochemistry and Physiology A-molecular & Integrative Physiology | 2008
T.B.H. (Theo) Geijtenbeek; Sonja I. Gringhuis; J. den Dunnen
Archive | 2007
T.B.H. (Theo) Geijtenbeek; K.P.J.M. van Gisbergen; Y. (Yvette) van Kooyk
Archive | 2007
Wilbert Bitter; T.B.H. (Theo) Geijtenbeek; Ben J. Appelmelk; Y. (Yvette) van Kooyk; Christina M. J. E. Vandenbroucke-Grauls
Archive | 2007
T.B.H. (Theo) Geijtenbeek; Y. (Yvette) van Kooyk; Annemarie N. Lekkerkerker